These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 301391)
1. 2,3-Dihydro-9H-isoxazolo[3,2-b]quinazolin-9-ones and 3,4-dihydro-(1,2)-oxazino [3,2-b]quinazolin-10(2H)-ones. Reisner DB; Ludwig BJ; Simon E; Dejneka T; Sofia RD Arzneimittelforschung; 1977; 27(4):766-70. PubMed ID: 301391 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-inflammatory activity of 3,3a-dihydro-2H,9H-isoxazolo [3,2-b] [1,3]benzoxazin-9-ones and related compounds. Reisner DB; Ludwig BJ; Stiefel FJ; Gister S; Meyer M; Powell LS; Sofia RD Arzneimittelforschung; 1977; 27(4):760-6. PubMed ID: 301390 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of 2,3-dihydro-9H-isoxazolo [3,2-b] quinazolin-9-one (W-2429. Part 1: Analgesic, antipyretic and antiedema activity. Sofia RD; Diamantis W; Ludwig BJ Arzneimittelforschung; 1977; 27(4):770-82. PubMed ID: 17418 [No Abstract] [Full Text] [Related]
4. Synthesis and pharmacological study of some 3-(isoxazol-5-yl)-quinazolin-4(3H)-ones. Plescia S; Daidone G; Raffa D; Bajardi ML; Caruso A; Cutuli V; Amico-Roxas M Farmaco; 1992 Apr; 47(4):465-75. PubMed ID: 1388594 [TBL] [Abstract][Full Text] [Related]
5. Studies on quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides. 8.1, 2 synthesis and pharmacological evaluation of tricyclic fused quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides as potential alpha1-adrenoceptor antagonists. Chern JW; Tao PL; Wang KC; Gutcait A; Liu SW; Yen MH; Chien SL; Rong JK J Med Chem; 1998 Aug; 41(17):3128-41. PubMed ID: 9703460 [TBL] [Abstract][Full Text] [Related]
6. 2H-pyrano[2,3-f]quinazoline derivatives with platelet antiaggregating and other activities. Longobardi M; Mariani E; Bargagna A; Schenone P; Budetta S; Losasso C; Cenicola ML; Donnoli D; De Santis D; Marmo E Farmaco; 1991 Jan; 46(1):99-110. PubMed ID: 2054045 [TBL] [Abstract][Full Text] [Related]
7. Toxicological investigation of 2,3-dihydro-9H-isoxazolo[3,2-b]quinazolin-9-one (W-2429). Acute and subacute toxicity in mice, rats and dogs. Banerjee BN; Sofia RD; Ivins NJ; Ludwig BJ Arzneimittelforschung; 1977; 27(4):793-801. PubMed ID: 301393 [TBL] [Abstract][Full Text] [Related]
8. Absorption, distribution and metabolic fate of 2,3-dihydro-9H-isoxazolo-[3,2-b]quinazolin-9-one (W2429). Edelson J; Douglas JF; Ludwig BJ Arzneimittelforschung; 1977; 27(4):789-93. PubMed ID: 301392 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties of 2,3-dihydro-9H-isoxazolo[3,2-b]-quinazolin-9-one (W-2429. Part 2: General pharmacological investigation. Sofia RD; Diamantis W; Gordon R; Edelson J; Ludwig BJ Arzneimittelforschung; 1977; 27(4):782-9. PubMed ID: 405977 [No Abstract] [Full Text] [Related]
10. Researches on antiinflammatory agents. Studies on some new 3-(pyrazol-5-yl)-1,2,3-benzotriazin-4(3H)-ones and -quinazolin-4(3H)-ones. Daidone G; Plescia S; Raffa D; Bajardi ML; Matera M; Caruso A; Leone MG Farmaco; 1990 Apr; 45(4):391-8. PubMed ID: 2400513 [TBL] [Abstract][Full Text] [Related]
11. A new therapeutic approach in Parkinson's disease: some novel quinazoline derivatives as dual selective phosphodiesterase 1 inhibitors and anti-inflammatory agents. Laddha SS; Bhatnagar SP Bioorg Med Chem; 2009 Oct; 17(19):6796-802. PubMed ID: 19744861 [TBL] [Abstract][Full Text] [Related]
12. 3-(3-ethylphenyl)-2-substituted hydrazino-3H-quinazolin-4-one derivatives: new class of analgesic and anti-inflammatory agents. Alagarsamy V; Raja Solomon V; Sheorey RV; Jayakumar R Chem Biol Drug Des; 2009 Apr; 73(4):471-9. PubMed ID: 19291107 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, analgesic and anti-inflammatory evaluation of some new 3H-quinazolin-4-one derivatives. Alafeefy AM; Kadi AA; El-Azab AS; Abdel-Hamide SG; Daba MH Arch Pharm (Weinheim); 2008 Jun; 341(6):377-85. PubMed ID: 18535995 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel 2-substituted-quinazolin-4(3H)-ones as potent analgesic and anti-inflammatory agents. Rather BA; Raj T; Reddy A; Ishar MP; Sivakumar S; Paneerselvam P Arch Pharm (Weinheim); 2010 Feb; 343(2):108-13. PubMed ID: 20108268 [TBL] [Abstract][Full Text] [Related]
15. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity. Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053 [TBL] [Abstract][Full Text] [Related]
16. Comparative anti-inflammatory, analgesic, and antipyretic activities of 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one and 5-chlorosalicylic acid in rats. Sofia RD; Diamantis W; Ludwig BJ J Pharm Sci; 1975 Aug; 64(8):1321-4. PubMed ID: 1151704 [TBL] [Abstract][Full Text] [Related]
17. Analogue-based design, synthesis and docking of non-steroidal anti-inflammatory agents. Part 2: methyl sulfanyl/methyl sulfonyl substituted 2,3-diaryl-2,3-dihydro-1H-quinazolin-4-ones. Manivannan E; Chaturvedi SC Bioorg Med Chem; 2012 Dec; 20(24):7119-27. PubMed ID: 23146282 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, analgesic, anti-inflammatory and antibacterial activities of some novel 2-methyl-3-substituted quinazolin-4-(3H)-ones. Alagarsamy V; Murugananthan G; Venkateshperumal R Biol Pharm Bull; 2003 Dec; 26(12):1711-4. PubMed ID: 14646176 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacological evaluation of 3-cyclohexyl-2-substituted hydrazino-3H-quinazolin-4-ones as analgesic and anti-inflammatory agents. Alagarsamy V; Shankar D; Solomon VR; Sheorey RV; Parthiban P Acta Pharm; 2009 Mar; 59(1):75-88. PubMed ID: 19304560 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological investigation of novel 3-(3-methylphenyl)-2-substituted amino-3H-quinazolin-4-ones as analgesic and anti-inflammatory agents. Alagarsamy V; Dhanabal K; Parthiban P; Anjana G; Deepa G; Murugesan B; Rajkumar S; Beevi AJ J Pharm Pharmacol; 2007 May; 59(5):669-77. PubMed ID: 17524232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]